brimonidine tartrate has been researched along with Carcinoma, Basal Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, E; Huang, CC; Kwak, YJ; Patel, RA | 1 |
Schleichert, R; Weiss, E | 1 |
1 trial(s) available for brimonidine tartrate and Carcinoma, Basal Cell
Article | Year |
---|---|
Randomized controlled pilot study of the preoperative use of brimonidine 0.33% topical gel for hemostasis in Mohs micrographic surgery.
Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Gels; Hemostatic Techniques; Humans; Mohs Surgery; Pilot Projects; Preoperative Care; Prospective Studies; Skin Neoplasms | 2017 |
1 other study(ies) available for brimonidine tartrate and Carcinoma, Basal Cell
Article | Year |
---|---|
Topical Brimonidine Gel as a Hemostatic Agent After Dermatologic Surgery.
Topics: Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Carcinoma, Basal Cell; Female; Gels; Hemostatics; Humans; Middle Aged; Mohs Surgery; Nose Neoplasms; Quinoxalines; Surgical Flaps | 2015 |